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coverage of at least 95% of the prescribed dose was achieved, the 
treatment plan would be considered as clinical acceptable.  
Results: D99% coverage for the gold standard CTV was achieved in for 
69% of the patients using a margin of 1/4 mm in/out of plane, for the 
propagated CTV, which is about the voxel size of the MRI. D99% 
coverage for the gold standard GTV of was achieved for 89% of the 
patients using a margin of 8/8 mm in/out of plane for the propagated 
GTV. OAR doses remained far less then clinical criteria in all 
treatment plans. All treatment plans were made using a class solution 
objectives set. 
 
 
Conclusions: Online MRI-guided ART seems feasible using only a small 
margin added to the automatically generated contours. Failures were 
seen only in patients with large daily variations in rectum filling. 
Currently, the used DIR method cannot account for these large 
deformations. Further improvements on the DIR have to be made to 
make feasible treatment plans for these patients in an automated 
workflow. For delivering the GTV boost, a somewhat larger margin 
was needed and needs to be further optimized.  
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Purpose/Objective: Hyperthermia is a clinical application of heat in 
which tumour temperatures are raised to 40-45°C. Hyperthermia is a 
proven radiosensitizer, which significantly improves clinical outcome 
for several tumour sites. Contrary to most anti-cancer treatments 
hyperthermia has no serious side effects when administered properly. 
Therefore, hyperthermia might be a good alternative for dose 
escalation, for instance for treatment of prostate tumours. This is 
expected to improve tumour control, while avoiding an increase in 
dose to organs at risk; e.g. the rectum. 
Purpose: of this study was to develop a method to quantify the 
therapeutic effect of radiosensitization by hyperthermia. To this end, 
a numerical method was proposed to convert radiotherapy dose 
distributions with hyperthermia to equivalent dose distributions 
without hyperthermia. 
Materials and Methods: For 15 prostate cancer patients clinical IMRT 
plans were created. Patients received a total dose of 70 Gy on the 
PTV, delivered in 35 fractions of 2 Gy, with an integrated boost 
delivering 77 Gy to the prostate. To simulate a clinically relevant 
heterogeneous temperature distribution, hyperthermia treatment 
planning was performed for heating with the 70 MHz AMC-8 system 
using our in-house developed treatment planning system. The 
temperature dependent parameters α (Gy-1) and β (Gy-2) of the linear-
quadratic model (LQ-model) for prostate cancer were estimated from 
literature. In line with clinical observations, no thermal effect was 
assumed for normal tissue. The IMRT plans and temperature 
distributions were exported to our in-house developed research 
radiotherapy treatment planning system and equivalent dose 
distributions without hyperthermia were calculated using the LQ-
model. 
Results: The average tumour temperatures T90, T50 and T10 in the 
PTV were 40.5°C, 41.6°C and 42.4°C, respectively. The minimum, 
maximum and average radiotherapy doses were 62.9 Gy, 81.0 Gy and 
76.0 Gy, respectively. The equivalent minimum, maximum and 
average dose reflecting the radiosensitization by hyperthermia were 
70.3 Gy, 93.6 Gy and 86.3 Gy, respectively, for a linear increase of α 
with temperature. This can be considered similar to a dose escalation. 
Furthermore, the PTV coverage by the 95% isodose level improved by 
adding hyperthermia (Fig. 1). In IMRT dose optimization the dose to 
organs at risk (e.g. the rectum) can be a limiting factor, yielding 
under-dosage in a part of the PTV. Hyperthermia reduces the impact 
of these limitations. 
 
 
Conclusions: A model to quantify the effect of combined 
hyperthermia and radiotherapy in terms of equivalent dose 
distributions was presented. Adding hyperthermia can be considered 
similar to a dose escalation. This model is useful to predict interaction 
of different cancer treatments and may be very helpful in discussions 
on dose escalation.  
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Purpose/Objective: Historically a number of techniques have been 
described that use combined photon and electron fields to conform 
the dose with depth. In recent years however this sort of treatment 
has largely been replaced with photon IMRT. It is proposed that to 
further improve dose distributions electron fields could be re-
introduced to IMRT. The electron beam limited range and large 
penumbra could be balanced by modulating with photon MLC and 
combining with existing photon IMRT techniques. By finding the 
optimum mix of electron energies and photons it may be possible to 
reduce exposure to critical organs and reduce integral doses. The 
perceived disadvantages of high surface dose characterising electron 
beams becomes an advantage for cases where the CTV extends to the 
surface. 
The purpose of this study is to develop a novel optimisation algorithm 
for combined electron and photon IMRT that allows spatial and energy 
modulation with standard unmodified linacs. 
Materials and Methods: Isocentric electron beamlets delivered 
through the photon MLC of an Elekta linac were calculated using 
BEAMnrc Monte Carlo dose simulations. The CERR environment (A 
Computational Environment for Radiotherapy Research, Washington 
University Medical Centre) was used to manipulate the electron 
beamlets and to calculate photon beamlets using the quadrant infinite 
beam (QIB) dose calculation engine within CERR. An algorithm was 
then developed to optimise the combined electron and photon dose 
distribution. Beams are manually positioned to cover the target, with 
a single electron field positioned as a boost over the superficial 
section of tumour. The optimisation is then split into three stages. (1) 
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A quadratic programming optimisation is used to modulate an electron 
beam for spatial fluence and energy by optimising the weights of 
overlapping beamlets. (2) The 6MV X-ray beamlet weights are 
optimised to cover voxels not reached by the electron beam. (3) An 
iterative optimisation minimises a cost function designed to 
incorporate the advantages and limitations of the technique. A 
number of optimisation methods, including evolutionary algorithms, 
have been evaluated for the minimisation this cost function. 
Results: The algorithm has been tested for simple geometries and can 
produce conformal dose distributions with low dose to proximal 
structures and a high dose to the skin surface. In the central part of 
the electron field the algorithm successfully optimises the weights of 
electron beamlets to remove the large electron penumbra for the un-
modulated beam treated through the MLC. Electron energies are 
selected by the algorithm to optimise the dose with depth. Target 
volumes not covered by the electron field are covered by the 
compensating photon fields 
Conclusions: An IMRT mixed energy mixed modality optimisation 
algorithm has been developed to optimise dose with the electron field 
as an energy modulated boost delivered through photon MLC.  
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Purpose/Objective: The selection of appropriate radiation incidence 
directions may influence the quality of the treatment plans. However, 
many times in clinical practice, beam directions continue to be 
manually selected with consumption of large amounts of time and no 
guarantee of optimality. Some commercial treatment planning 
systems are designed to use local search and/or gradient-based 
algorithms in the beam angle space to address the beam angle 
optimization (BAO) problem. Due to the many local minima aspect of 
the BAO problem, such approaches are not efficient. We propose a 
novel approach that uses beam’s-eye-view ray tracing dose metrics 
within pattern search methods (PSM) in the optimization of the highly 
non-convex BAO problem. 
Materials and Methods: PSM are derivative-free optimization 
algorithms that require few function evaluations to progress and 
converge and have the ability to better avoid local entrapment 
making them a suitable approach for the resolution of the BAO 
problem. PSM are organized around two phases at every iteration: one 
that assures convergence to a local minimizer (poll), and the other 
(search) where flexibility is conferred to the method allowing 
searches away from the neighborhood of the current iterate. Beam’s-
eye-view dose metrics assign a score to each beam direction and can 
be used within the PSM furnishing a priori knowledge of the problem 
so that directions with larger dosimetric scores are tested first 
improving results and computational time. Locally advanced head and 
neck clinical cases were selected to test this approach. The planning 
target volumes included the primary tumor, the high and low risk 
lymphnodes. Organs-at-risk (OARs) included the parotids, the 
brainstem, and the spinal cord. For each case, a setup with seven equi 
distant beams was choosen using CERR (computational environment 
for radiotherapy research). The resulting treatment plan was then 
compared with the plan using the optimal beam setup obtained by 
PSM incorporating beam’s-eye-view dose metrics (PSM-BEVD). 
Results: For the clinical cases retrospectively tested, the use of prior 
knowledge of the patient in our tailored approach showed a positive 
influence on the quality of the local minimizer found. The objective 
function value of the fluence optimization problem was reduced in 
average more than 10% when using the optimal beam setup obtained 
by PSM-BEVD instead of the traditional equidistant beam arrangement. 
The improvement of the local solutions in terms of objective function 
value corresponded to high quality treatment plans with better target 
coverage and with improved organ sparing. 
Conclusions: PSM-BEVD has shown ability to avoid local entrapment 
and efficiency on the number of function evaluations leading to a fast 
convergence which is of the utmost importance in a busy clinical 
practice. Our results have shown that a global derivative-free beam 
angle search yields superior quality plans.  
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Purpose/Objective: Recently, there has been an increased focus on 
using diffusion-weighted magnetic resonance imaging (DWI) to 
evaluate tumor response to radiotherapy (RT). The parameter used to 
quantify tissue diffusion is the apparent diffusion coefficient (ADC). In 
this work we examine some properties of the calculated ADC for 
rectal tumors: (i) the short term reproducibility of the ADC, (ii) how 
the ADC depends on the range of b-values and (iii) the dependence on 
scan time.  
Materials and Methods: In our department, rectal cancer patients 
referred for concomitant chemoradiotherapy receive a pre-treatment 
MR scan including DWI. The DWI sequence has 11 b-values between 0 
and 1100, in-plane resolution is 3x3mm and slice thickness 4.6mm. 
Patients have received either a single DWI scan with 4 signal averages 
(NSA) or two consecutive scans each with 2 NSA. Here we present data 
from 27 patients. Regions of interest (ROI) are drawn using a semi-
automated algorithm, which, for each individual patient, selects areas 
exhibiting an atypically high signal. This is evaluated on the b = 1100 
slices. This method provides a consistent way of defining ROIs. The 
ROIs defined this way corresponds well to the areas exhibiting low 
ADC. For each patient ADC is calculated on a voxel by voxel basis by 
fitting a mono-exponential function to the signal. The ADC of the ROI 
is then defined as the mean of the voxel ADCs over the ROI.To test (i) 
reproducibility, we compare the ADC between the two 2NSA scans as 
well as evaluating the images by eye. We also examine the effect of 
applying a goodness-of-fit estimation to each fitted voxel and 
including only voxels where a mono-exponential fit is a good 
description of the signal decay.Testing (ii) ADC dependency on the 
range of b-values and (iii) on the scan time is done by comparing the 
ADCs for calculations on different subsets of b-values and signal 
averages.  
Results: We find that (i) the calculated ADCs are highly reproducible, 
with variations between the ADC from the first and second scan being 
on average 5-10% depending on the sequence of b-values used. 
However, individual scans can show much larger variation. Including 
the goodness-of-fit calculations improves the reproducibility to 2-4% 
and especially reduces cases of large differences. (ii) The ADC 
depends on the range of b-values used, showing a systematic increase 
as b-values shift towards lower values. This effect is mostly patient 
independent. (iii) We find no evidence of the number of signal 
averages affecting the ADC. 
Conclusions: We have found that for rectal tumors the calculation of 
an ADC value is (i) reproducible, but to achieve the best results, and 
especially to avoid large deviations it is preferably to include a 
goodness-of-fit estimate. (ii) The calculated ADC depends on the 
range of b-values used. The mostly patient independent nature of this 
scaling suggests, that it may be possible to make a mapping between 
different b-value ranges. (iii) The calculated ADC does not depend on 
the number of signal averages.  
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Purpose/Objective: Esophageal tumours are difficult to delineate on 
CT images as there is no distinct contrast between healthy tissue and 
the tumour. Therefore, delineation is merely based on anatomical 
abnormalities such as wall thickening. For other tumour sites (e.g. 
prostate) it was shown that diffusion-weighted MRI (DWI) can improve 
tumour visualization. Unfortunately, DWI is prone to geometrical 
inaccuracies due to distortions in the main magnetic field. Those 
distortions are most prominent at locations with changing magnetic 
susceptibility (e.g. close to air/tissue boundaries). This might prove to 
be a problem for esophageal imaging. Aim of this work is to correct 
the geometrical distortions using a magnetic field distortion map and 
to investigate the residual errors. 
Materials and Methods: Three patients eligible for neoadjuvant 
chemoradiation were included in this pilot study. A free-breathing 
DWI scan with echo-planar readout was optimized to reduce the effect 
of field distortions. Heavy diffusion weighting (b=800 s/mm2) was 
